A. Jo Chien, MD

Additional Websites

• Physician Referral Directory

Education

Stanford University, Stanford, CA, BS w/ Honors, 1998, Biological Sciences
Harvard Medical School, Boston, MA, MD, 2003

Professional Experience

• 2003-2004
  Intern, Internal Medicine, Massachusetts General Hospital, Boston, MA
• 2004-2006
  Resident, Internal Medicine, Massachusetts General Hospital, Boston, MA
• 2006-2009
  Fellow, Hematology and Oncology, UCSF, San Francisco, CA
• 2007-2009
  Chief Fellow, Hematology and Oncology, UCSF, San Francisco, CA

Honors & Awards

• 1994
  Robert C. Byrd California State Scholarship
• 1994
  Stanford University Presidential Scholar
• 1996
  Howard Hughes Undergraduate Research Grant
• 1998
  Phi Beta Kappa Society Electee
• 1998
  Stanford University Department of Biological Sciences Graduate of Distinction
• 2003
  Massachusetts Medical Society and Alliance Charitable Foundation International Health Grant
• 2008
  ASCO Young Investigator Award
• 2008
  ASCO Foundation Merit Award
• 2008
  American Cancer Society Postdoctoral Fellowship

Selected Publications

1. Chien AJ, Rugo HS. Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancer. Breast Cancer Res Treat. 2013 Jan; 137(1):1-12.
   View on PubMed
2. Bock M, Moore D, Hwang J, Shumay D, Lawson L, Hamolsky D, Esserman L, Rugo H, Chien AJ, Park J, Munster P, Melisko M. The impact of an electronic health questionnaire on symptom management and behavior reporting for breast cancer survivors. Breast Cancer Res Treat. 2012 Aug; 134(3):1327-35.
   View on PubMed
3. Rugo HS, Chien AJ, Franco SX, Stopeck AT, Glencer A, Lahiri S, Arbushites MC, Scott J, Park JW, Hudis C, Nulsen B, Dickler MN. A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer. Breast Cancer Res Treat. 2012 Jul; 134(1):13-20.
   View on PubMed
4. Letourneau JM, Ebbel EE, Katz PP, Katz A, Ai WZ, Chien AJ, Melisko ME, Cedars MI, Rosen MP. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer. 2012 Mar 15; 118(6):1710-7.
   View on PubMed
5. Letourneau JM, Ebbel EE, Katz PP, Oktay KH, McCulloch CE, Ai WZ, Chien AJ, Melisko ME, Cedars MI, Rosen MP. Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer. Cancer. 2012 Apr 1; 118(7):1933-9.
   View on PubMed
6. Chien AJ, Rugo HS. The cardiac safety of trastuzumab in the treatment of breast cancer. Expert Opin Drug Saf. 2010 Mar; 9(2):335-46.
   View on PubMed
7. Chien AJ, Illi JA, Ko AH, Korn WM, Fong L, Chen LM, Kashani-Sabet M, Ryan CJ, Rosenberg JE, Dubey S, Small EJ, Jahan TM, Hylton NM, Yeh BM, Huang Y, Koch KM, Moasser MM. A phase I study of a 2-day lapatinib chemosensitization pulse preceding nanoparticle albumin-bound Paclitaxel for advanced solid malignancies. Clin Cancer Res. 2009 Sep 1; 15(17):5569-75.
   View on PubMed
8. Chien AJ, Moasser MM. Cellular mechanisms of resistance to anthracyclines and taxanes in cancer: intrinsic and acquired. Semin Oncol. 2008 Apr; 35(2 Suppl 2):S1-S14; quiz S39.
   View on PubMed
9. Chien AJ, Goss PE. Aromatase inhibitors and bone health in women with breast cancer. J Clin Oncol. 2006 Nov 20; 24(33):5305-12.
   View on PubMed

View on UCSF Profiles